Multiple Molecular Marker Array-Based Evaluation (January 2006)

Why This Topic Matters

Array-based genetic testing introduced new reporting considerations for physician work, laboratory involvement, and related preparatory services. Understanding the article helps readers identify where this CPT code series fits within molecular pathology reporting and why it differs from other molecular diagnostic code groups.

Article Sections

1. Coding Communication: Multiple Molecular Marker Array-Based Evaluation

   Introduces array-based molecular testing and explains the general purpose of the new CPT code series. It also summarizes how the article frames related specimen preparation and ancillary molecular diagnostic services.

2. Array-Based Evaluations vs Molecular Diagnostics

   Compares the array-based evaluation code series with the broader molecular diagnostics section of CPT. It discusses the relationship between these code families and the general role of interpretation and reporting within this context.

3. Multiple Molecular Marker Array-Based Evaluations

   Describes the kinds of clinical situations in which array-based evaluations may be used. It provides broad examples across disease categories and introduces the article’s illustrative coding scenarios.

4. Clinical Example: Code 88385

   Presents a detailed pathology example involving array-based evaluation in an oncology setting. The example illustrates the broader workflow and documentation elements discussed in the article.

5. Clinical Example: Code 88386

   Presents a second clinical example involving array-based evaluation and genomic testing in a hematology/oncology context. The example shows another use of the article’s general coding framework.